Articles tagged with Chronic Obstructive Pulmonary Disease
The ATS 2023 International Conference is highlighting recent advancements in COPD and asthma treatment through its Breaking News: Clinical Trial Results in Pulmonary Medicine session. Emerging biologics will be discussed alongside existing COPD treatment options.
Researchers found that vaping in the presence of supplemental oxygen can ignite oxygen, leading to burns, fires, or explosions. The risk is particularly concerning for patients with end-stage COPD on oxygen who want to quit smoking by switching to vaping.
The CHEST journal April issue features cutting-edge research on asthma, chronic obstructive pulmonary disease (COPD), and sarcoidosis. Key findings include the potential of efzofitimod as a treatment for managing sarcoidosis. The journal also showcases innovative approaches to clinical practice and education in chest medicine.
Researchers have identified a new cell state in embryonic airway development, which may lead to new approaches for treating chronic respiratory diseases. The discovery highlights the crucial role of cellular heterogeneity in shaping airway biology.
A study of over 2.6 million people from Finland and Norway found that babies born preterm are more likely to develop asthma or chronic obstructive pulmonary disease (COPD) in adulthood. The risk was highest among those born extremely preterm, before 28 weeks of gestation.
A comprehensive tool assessing burden of chronic conditions shows valid and reliable results compared to clinical surveys in patients with COPD, diabetes, and asthma. The Assessment of Burden of Chronic Conditions (ABCC) scale integrates patient experience into daily care, facilitating shared decision making and self-management.
Research published in Annals of the Rheumatic Diseases found that people with atopic diseases like asthma or eczema are at a heightened risk of developing osteoarthritis. Drugs used to dampen down allergic reactions may help lessen this risk, suggesting a potential new approach to treating the condition.
The study found that vaccination significantly reduces the risk of long COVID, while factors such as being overweight, female, smoker, or over 40 increase the likelihood of developing the condition. Vaccination halves people's risk of developing long Covid
A population data linkage study found fewer people in Wales diagnosed with long-term conditions in 2020 and 2021 than expected, indicating a potential backlog of undiagnosed patients. This disparity affects chronic obstructive pulmonary disease (COPD) and anxiety disorders, corresponding to over 30 and 80 missing diagnoses respectively.
Researchers have designed a potent and selective compound that could lead to new therapies for asthma and COPD by activating bitter taste receptors. The new ligand is six times more potent than a known NSAID and highly selective for the TAS2R14 subtype, minimizing potential side effects.
Researchers at the University of Cincinnati developed an innovative breathing device called PEP Buddy, which improves symptoms of breathlessness, quality of life, and oxygen levels in people with COPD. The study found significant reductions in shortness of breath and improvements in quality of life among participants.
The March issue of CHEST journal features 44 articles on topics such as asthma, critical care, and sleep medicine. The journal also includes complementary web resources, including visual abstracts.
Alveolus Bio, a UAB startup, has received a $2.5 million FastTrack grant from the NIH to support the development of first-of-its-kind inhaled biotherapeutics for chronic lung disease COPD. The company aims to create FDA-approved treatments for 15.7 million people affected by COPD worldwide.
Contracting a lower respiratory tract infection in early childhood is associated with a higher risk of dying from respiratory disease as an adult. Children who had a LRTI by age two were almost twice as likely to die prematurely in adulthood.
A new study published in the European Respiratory Journal reports that children's lung capacity has improved in areas with decreased air pollution in Stockholm. The researchers found a 20% lower risk of significantly impaired lung function in participants living in areas with better air quality.
A new screening tool, CAPTURE, identifies roughly half of primary care patients with chronic obstructive pulmonary disease (COPD) that could benefit from available treatments. The study confirms the robust nature of this collaborative relationship between numerous stakeholders, particularly primary care-based research networks.
A nationwide study found that the CAPTURE screening tool identified roughly half of primary care patients with chronic obstructive pulmonary disorder (COPD) who could benefit from available treatments. However, the tool also flagged a large group of patients with breathing symptoms and abnormalities that didn't rise to the level of COPD.
A new screening tool, CAPTURE, has been developed to identify adults with undiagnosed COPD, with promising results in identifying moderate to severe cases. The study found that almost half of participants who had previously undiagnosed COPD were successfully identified by the tool.
A smart necklace called SmokeMon tracks a user's every puff and provides valuable insights into their smoking behavior. By analyzing heat signatures, the device can detect when a cigarette is being lit, how much smoke is inhaled, and when the person holds it to their mouth, helping to prevent relapse and improve quit rates.
The February issue of the CHEST journal features 37 articles exploring various topics in chest medicine, including asthma, COPD, and pulmonary vascular disease. The journal also highlights its equity topic collection, focusing on conditions that affect women, such as pulmonary arterial hypertension and sarcoidosis.
Researchers found that breathing muscle strength persisted for five weeks after training stopped, suggesting potential benefits for physical endurance and quality of life in individuals with chronic lung conditions. Inspiratory muscle training also reduced the metaboreflex, allowing for improved exercise endurance.
Researchers analyzed how immunological memory gets generated and maintained to understand its role in cancer and inflammatory diseases. They found that increased inflammation can actually reduce immunological memory, highlighting the need for regulation.
The January issue of the CHEST journal features a range of clinically relevant research on COPD, bronchiectasis, and pulmonary vascular disease. The journal's education portal offers continuing medical education (CME) credit for select articles.
A new study published in CMAJ found that COPD patients who undergo major surgery are more likely to die and incur higher healthcare costs than similar patients without COPD. The study included 932 patients aged 35+ in Ontario, with COPD patients being older, more frail, and having lower income.
The American Thoracic Society will host ATS 2023 in Washington, DC from May 21-24. The event will cover the latest developments in pulmonary, critical care, and sleep medicine. Register now to attend or access recorded sessions.
The December issue of CHEST journal features articles on COVID-19 lessons learned and future pandemic preparedness. The journal also explores various topics in chest medicine, including asthma, critical care, and sleep medicine.
A new study by University of Toronto researchers found that a strong majority of those diagnosed with COPD were in excellent mental health. 87% of older Canadians with COPD had no mental illness, highlighting the importance of social support and interventions to promote well-being.
Researchers have developed a new X-ray technology that visualizes lung tissue microstructure, providing additional information for accurate diagnosis. Dark-field X-ray images can differentiate between diseased and healthy lung tissue, potentially replacing computed tomography (CT) for repeated examinations.
Researchers found that using portable home air purifiers improved markers of cardiovascular health in people with COPD. The study tracked participants' lung and heart health over six months, revealing a 25% increase in heart rate variability among those using active HEPA and carbon filters.
A randomized Phase 3 study published in JAMA found that morphine does not improve symptoms of chronic breathlessness in patients with COPD. However, clinical experience suggests that morphine can provide relief in end-of-life situations or crisis scenarios.
The November issue of CHEST journal features new guidelines for perioperative management, studies on COVID-19 treatment and COPD treatment, as well as research on sleep apnea and long COVID. These findings have significant implications for patient care and healthcare resource use.
The study found that higher population density was associated with fewer steps taken by patients, more sedentary time, and worse exercise capacity. Longer pedestrian street lengths were associated with more steps and less sedentary time, while steeper terrain was linked to greater exercise capacity.
The October issue of CHEST journal showcases 43 clinically relevant articles on topics such as asthma, COPD, critical care, and sleep medicine. The journal also offers web and multimedia activities, including visual abstracts, to expand its reach.
Researchers found reduced lung function and scarring in mice exposed to e-cigarette vapor with or without nicotine. Female mice also showed increased body weight in adulthood. The study suggests vaping during pregnancy can have long-term health effects on offspring.
The September issue of CHEST journal features 40 articles on clinically relevant topics, including disparities in rural populations with idiopathic pulmonary fibrosis. The journal also offers complementary web and multimedia activities to expand its reach.
Researchers developed a mobile phone app using AI to accurately detect COVID-19 infection in people's voices, outperforming lateral flow tests. The app achieved an accuracy of 89% and can be used for remote testing, enabling rapid screening of populations.
Research finds dual bronchodilators offer little relief to adults with smoking-related respiratory issues, but no COPD diagnosis. The study highlights the importance of spirometry testing for accurate diagnoses and calls for new therapies for patients without COPD.
The August issue of the CHEST journal features 47 articles on clinically relevant topics such as asthma, COPD, and pulmonary vascular disease. A highlighted article examines barriers to palliative care in interstitial lung disease.
A large multicenter study found that smaller airways in women, independent of smoking status, are associated with a higher risk of COPD. Women's airways were found to be narrower and less efficient than men's airways, leading to poorer lung function and increased symptoms.
Chronic lung disease (COPD) is a major public health problem worldwide, affecting 212 million people, primarily due to smoking and air pollution. The study reveals that while age-adjusted rates have declined, absolute counts are rising, with COPD expected to become an even greater issue in the future.
Despite electronic health records, gaps in communication between primary care physicians and specialist physicians persist. The study found that 22% of PCPs report sending clinical information to specialists at the time of referral, and less than 35% receive information back after consultation.
A study of 17,000 US primary care patients with COPD found 49.9% experiencing multiple exacerbation episodes despite treatment. Patients reported high symptoms and breathlessness, highlighting the need for non-pharmacologic treatments and improved physician education.
The July issue of CHEST journal features 62 articles on clinically relevant topics, including asthma and COPD. The journal has received an Impact Factor of 10.262, an increase from 2020's Impact Factor of 9.410.
A secondary analysis of the CARDIA Lung study found that a substantial proportion of middle-aged adults with normal spirometry findings had emphysema on CT scan. Race-specific interpretations of spirometry may underestimate respiratory symptom burden and risk for death in Black adults, perpetuating structural racial inequities.
University of Missouri researchers develop wearable smart bioelectronic devices, including a 'smart' face mask that can monitor physiological status and detect respiratory problems. The masks also use laser-assisted fabrication to provide breathable soft electronics for better real-time health monitoring.
The American College of Chest Physicians' flagship journal CHEST published its June issue featuring 58 articles on various chest medicine topics, including asthma and COPD. The journal is set to expand with two new open-access journals, CHEST Pulmonary and CHEST Critical Care.
African Americans with chronic obstructive pulmonary disease (COPD) are more likely to experience flare-ups due to inadequate sleep, which may boost their risk by up to 95%. The study, published on June 6, 2022, suggests that poor sleep quality may partially explain why African American patients tend to fare worse than white patients. ...
A recent study published in Pharmaceutics suggests that berberine can suppress the proliferation of lung cancer cells, reduce airway inflammation, and modulate genes involved in inflammation. The researchers used liquid crystalline nanoparticles to enhance safety and effectiveness.
A world-first study reveals why people with COPD are at higher risk of developing severe COVID-19. Researchers found that COPD airway cells had a 24-fold greater infection with SARS-CoV-2, leading to increased viral load and inflammatory responses.
Researchers found that COPD leads to premature senescence of the immune system, reducing CD4+ and CD8+ T cells. This disruption impairs the immune system, making COPD patients more susceptible to infections.
The US Preventive Services Task Force (USPSTF) recommends against routine screening for chronic obstructive pulmonary disease (COPD) in asymptomatic adults who do not recognize or report respiratory symptoms. This decision is based on a lack of evidence showing the benefit of screening in preventing future cardiovascular events.
A new study from Norway found that COPD patients have a higher degree of coronary artery calcification and narrower coronary arteries. The researchers discovered an increased risk of coronary disease in COPD patients, independent of disease severity, emphasizing the importance of early detection.
Researchers found that hypoxia can activate immune cells called ILC2s, which respond to harmless environmental allergens and drive mucus production and inflammation in the lungs. The study identifies adrenomedullin as a new target for treating inflammatory and allergic lung diseases.
The May issue of the CHEST journal features 56 articles on clinically relevant topics such as asthma, COPD, and critical care. The journal also includes a special Adult Cystic Fibrosis Series with latest epidemiologic data and challenges in managing CF.
A study published in The Lancet Respiratory Medicine found that astegolimab reduced exacerbation rates by 22% and improved quality of life in patients with moderate-to-severe COPD. Benefits were seen in those with specific inflammatory signals and genetic markers.
Researchers developed a novel drug to reduce airway mucus that exacerbates common lung diseases. The treatment works by blocking the secretion of mucins, which can block airways and cause life-threatening symptoms.
The American College of Chest Physicians journal features cutting-edge original research on various chest medicine topics, including asthma, COPD, critical care, and sleep. The March issue includes a special series on nontuberculous mycobacterial pulmonary disease, offering insights into clinical epidemiology, risk factors, and diagnosis.
A new study published in Menopause found that obesity and abdominal obesity significantly increase the risk of chronic obstructive pulmonary disease (COPD) and asthma in premenopausal and postmenopausal women. Maintaining a healthy body weight is key to preventing these conditions.
A study by Baylor College of Medicine, Yale University and others found altered gene expression and cell interactions in epithelial, endothelial and macrophage cells in COPD. The research provides new insights into cellular injury and inflammation in the disease.
A mixed-method review and meta-analysis found that integrated palliative care in ambulatory settings has limited effect on reducing symptom burden, but improves health care utilization for U.S. adults with non-cancer related chronic illnesses. The models were also effective in increasing advanced directive documentation.